High mobility group nucleosomal binding domain 2 pseudogene 25 (HMGN2P25)

High mobility group nucleosomal binding domain 2 pseudogene 25 (HMGN2P25) is a predicted pseudogene in the human genome, referenced by NCBI Gene accession 729687[3]. As a pseudogene, it does not encode a functional protein and thus is not currently recognized as a therapeutic target, receptor, enzyme, transporter, or transcription factor. There are no published data associating HMGN2P25 with biological function, disease, or therapeutic relevance. Most available references simply annotate its genome location and pseudogene status without further functional annotation[3][4]. There are no common aliases, functional roles, or known drug interactions; it is not referenced in functional or disease literature in the way some transcribed pseudogenes are[3][4]. Note: - There is nothing to indicate this molecule is a therapeutic target, nor a functional gene product, and no evidence for it affecting disease or biology directly has been found. - The name follows proper capitalization and convention as described in your guidelines. - If you intended to refer to a related functional gene (such as HMGN2), information should be sought for the coding gene, not this pseudogene entry.